CMS proposed rule changes affecting payment structures for continuous glucose monitors, impacting companies like Tandem.
1 report, 1 independent
Updated Aug 8
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
CMS proposed rule changes affecting payment structures for continuous glucose monitors, impacting companies like Tandem.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Tandem
television film directed by Bernhard Stephan
Nothing else this week.
-
CMS
International law firm
Related events
- CMS uses RVU and AMA standards to manage payment rules for Medicare physician labor.
- CMS provides alternative analysis of MA overpayments while MedPAC analyzes spending in the privatized Medicare program.
- CMS rules are impacting American healthcare costs, and Congress is involved in building on these rules for transparency.
Coverage
Newest first; wire copies grouped- MedTech DiveTandem, Insulet monitoring CMS payment proposal for diabetes tech This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive new